Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3458)
All Articles published online
|
May 15, 2004 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang XL, Cui HF. Different therapy for different types of ulcerative colitis in China. World J Gastroenterol 2004; 10(10): 1513-1520 [PMID: 15133864 DOI: 10.3748/wjg.v10.i10.1513] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i10/1513.htm |
| Number | Citing Articles |
| 1 |
Ghania Sohail, Xiaoyu Xu, Mary C Christman, Thomas A Tompkins. Probiotic Medilac-S<sup>®</sup> for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis. World Journal of Clinical Cases 2018; 6(15): 961-984 doi: 10.12998/wjcc.v6.i15.961
|
| 2 |
Dajeong Kim, Dongsun Park, Jangbeen Kyung, Yun-Hui Yang, Ehn-Kyoung Choi, Yoon-Bok Lee, Hyun-Kyu Kim, Bang Yeon Hwang, Yun-Bae Kim. Anti-inflammatory effects ofHouttuynia cordatasupercritical extract in carrageenan-air pouch inflammation model. Laboratory Animal Research 2012; 28(2): 137 doi: 10.5625/lar.2012.28.2.137
|
| 3 |
Brian G Feagan, John K MacDonald, Brian G Feagan. Cochrane Database of Systematic Reviews. 2012; doi: 10.1002/14651858.CD000543.pub3
|
| 4 |
Si Wang, Lei Li, Yuhan Chen, Qian Liu, Shengyu Zhou, Ning Li, Yueying Wu, Jiali Yuan. Houttuynia cordata thunb. alleviates inflammatory bowel disease by modulating intestinal microenvironment: a research review. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1306375
|
| 5 |
Siddharth Singh, Joseph D. Feuerstein, David G. Binion, William J. Tremaine. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 2019; 156(3): 769 doi: 10.1053/j.gastro.2018.12.008
|
| 6 |
Irene Sonu, Ming Valerie Lin, Wojciech Blonski, Gary R. Lichtenstein. Clinical Pharmacology of 5-ASA Compounds in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 2010; 39(3): 559 doi: 10.1016/j.gtc.2010.08.011
|
| 7 |
T.V.M. Sreekanth, In Yong Eom. Biogenic Gold Nanoparticles and its Antibacterial Activities: Houttuynia Cordata Leaf Extract. Advanced Materials Research 2014; 1051: 392 doi: 10.4028/www.scientific.net/AMR.1051.392
|
| 8 |
E. R. Paine. Colonoscopic evaluation in ulcerative colitis. Gastroenterology Report 2014; 2(3): 161 doi: 10.1093/gastro/gou028
|
| 9 |
Prashant R. Mudireddy, Wojciech Blonski, Gary R. Lichtenstein. Medical Therapy of Ulcerative Colitis. 2014; : 69 doi: 10.1007/978-1-4939-1677-1_7
|
| 10 |
Cynthia W. Ko, Siddharth Singh, Joseph D. Feuerstein, Corinna Falck-Ytter, Yngve Falck-Ytter, Raymond K. Cross, Seth Crockett, Yngve Falck-Ytter, Joseph Feuerstein, Steven Flamm, John Inadomi, Cynthia Ko, Thiruvengadam Muniraj, Robert O’Shea, John Pandolfino, Amit Patel, Ravi Sharaf, Shazia Siddique, Grace Su, Kenneth Wang, Adam Weizman. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. Gastroenterology 2019; 156(3): 748 doi: 10.1053/j.gastro.2018.12.009
|
| 11 |
Lloyd R Sutherland, John K MacDonald, Lloyd R Sutherland. Cochrane Database of Systematic Reviews. 2006; doi: 10.1002/14651858.CD000543.pub2
|
| 12 |
Sunhee Shin, Seong Soo Joo, Jeong Hee Jeon, Dongsun Park, Min-Jung Jang, Tae-Ook Kim, Hyun-Kyu Kim, Bang Yeon Hwang, Ki-Yon Kim, Yun-Bae Kim. Anti-inflammatory effects of aHouttuynia cordatasupercritical extract. Journal of Veterinary Science 2010; 11(3): 273 doi: 10.4142/jvs.2010.11.3.273
|
| 13 |
HaiJing Zhang, GuangMing Song, ZhiHui Zhang, HuaChen Song, XiaoNan Tang, AnJun Deng, WenJie Wang, LianQiu Wu, HaiLin Qin. Colitis Is Effectively Ameliorated by (±)-8-Acetonyl-dihydrocoptisine via the XBP1-NF-κB Pathway. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00619
|
| 14 |
Yongjun Wang, Claire E Parker, Tania Bhanji, Brian G Feagan, John K MacDonald. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2016; doi: 10.1002/14651858.CD000543.pub4
|
| 15 |
Alistair Murray, Tran M Nguyen, Claire E Parker, Brian G Feagan, John K MacDonald. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database of Systematic Reviews 2020; 2020(8) doi: 10.1002/14651858.CD000543.pub5
|
| 16 |
Amany A. Abdin, Eman M. Saeid. An experimental study on ulcerative colitis as a potential target for probiotic therapy by Lactobacillus acidophilus with or without “olsalazine”. Journal of Crohn's and Colitis 2008; 2(4): 296 doi: 10.1016/j.crohns.2008.04.002
|
| 17 |
Shekoufeh Nikfar, Roja Rahimi, Ali Rezaie, Mohammad Abdollahi. A Meta-Analysis of the Efficacy of Sulfasalazine in Comparison with 5-Aminosalicylates in the Induction of Improvement and Maintenance of Remission in Patients with Ulcerative Colitis. Digestive Diseases and Sciences 2009; 54(6): 1157 doi: 10.1007/s10620-008-0481-x
|
| 18 |
Jiangang Fu, Ling Dai, Zhang Lin, Hongmei Lu. <i>Houttuynia cordata</i> Thunb: A Review of Phytochemistry and Pharmacology and Quality Control. Chinese Medicine 2013; 4(03): 101 doi: 10.4236/cm.2013.43015
|